BiotechTube
Home/enGene/Richard Gammans
RG

Richard Gammans

Chief Development Officer

enGene

Therapeutic Areas

OncologyInflammatory DiseasesGenetic Disorders

enGene Pipeline

DrugIndicationPhase
EG-70BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) with Carcinoma in Situ (CIS)Phase 1/2

Leadership Team at enGene

JH
Jason Hanson
Chief Executive Officer
AR
Alexey Revenko
Chief Scientific Officer and Co-Founder
IM
Ian McGowan
Chief Medical Officer
PY
Peter Yee
Chief Financial Officer
View full enGene profile